Breaking News
Close
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

Zomedica Pharmaceuticals Corp (ZOM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Zomedica Pharma's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.2352 +0.0098    +4.35%
20:44:25 - Real-time Cboe. Currency in USD ( Disclaimer )
  • Volume: 24,753,058
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.2220 - 0.2390
Type:  Equity
Market:  United States
ISIN:  CA98980M1095 
CUSIP:  98980M109
Zomedica Pharma 0.2352 +0.0098 +4.35%
IndustryHealth Care Equipment & Supplies
SectorHealthcare
Employees

47

Equity Type

ORD

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.

Contact Information

Top Executives

Name Age Since Title
Jeffrey Michael Rowe 65 2016 Independent Chairman
Rodney J. Williams 59 2016 Independent Director
Marc Bailie - - Member of Scientific Advisory Board
Johnny D. Powers 60 2019 Independent Director
Sean M. Whelan 51 2021 Independent Director
Christopher Ross MacLeod 52 2020 Independent Director
Ann R. Donoghue - - Member of Scientific Advisory Board
Robert Cohen 64 2020 Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ZOM Comments

Write your thoughts about Zomedica Pharmaceuticals Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Peter Owt
Peter Owt Dec 16, 2021 17:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
An easy buy.
Peter Owt
Peter Owt Dec 01, 2021 13:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Now my biggest holding. Strong new management.
Billionaire Dreams
Billionaire Dreams Oct 05, 2021 22:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Easy HODL. Assays will be released soon
Peter Owt
Peter Owt Sep 20, 2021 15:37
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buying and lowering my average.Future is very bright for Zomedica.Do your own DD and look beyond the FUD.
five for best
five for best Sep 14, 2021 15:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
try it for 500 $
five for best
five for best Sep 14, 2021 15:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
anybody buy it 1000 very easy to become millionaire
five for best
five for best Sep 14, 2021 15:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy again
five for best
five for best Sep 14, 2021 15:13
Saved. See Saved Items.
This comment has already been saved in your Saved Items
up up
five for best
five for best Sep 14, 2021 15:08
Saved. See Saved Items.
This comment has already been saved in your Saved Items
quickly up
five for best
five for best Sep 14, 2021 15:00
Saved. See Saved Items.
This comment has already been saved in your Saved Items
never a chance to get
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Our Apps
DOWNLOAD APPApp store
Investing.com
© 2007-2022 Fusion Media Limited. All Rights Reserved.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
  • Sign up for FREE and get:
  • Real-Time Alerts
  • Advanced Portfolio Features
  • Personalized Charts
  • Fully-Synced App
Continue with Google
or
Sign up with Email